Future drugs may snap supply chain fueling breast cancer
World Pharma News | Mar 11, 2025
Novel therapies for treating HR+/HER2– metastatic breast cancer: PROTAC and beyond
MDlinx | Mar 09, 2025
Panelists discuss: Why do HR+ BC patients pause or discontinue endocrine therapy?
MDlinx | Mar 08, 2025
From early stage to advanced BC: The latest buzz on HER2, HER3, and TROP2
MDlinx | Mar 08, 2025
Newly discovered biomarkers could improve endometrial cancer treatment
MedicalXpress Breaking News-and-Events | Mar 06, 2025
Barriers in cancer screening for people with intellectual disabilities highlight need for tailored support
MedicalXpress Breaking News-and-Events | Mar 06, 2025